BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18369777)

  • 1. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E; Boese Q; Khvorova A; Karpilow J
    Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and function of small interfering RNAs and microRNAs.
    Cullen BR
    Virus Res; 2004 Jun; 102(1):3-9. PubMed ID: 15068874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi microarray analysis in cultured mammalian cells.
    Mousses S; Caplen NJ; Cornelison R; Weaver D; Basik M; Hautaniemi S; Elkahloun AG; Lotufo RA; Choudary A; Dougherty ER; Suh E; Kallioniemi O
    Genome Res; 2003 Oct; 13(10):2341-7. PubMed ID: 14525932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-based functional pharmacogenomics.
    Tuzmen S; Tuzmen P; Arora S; Mousses S; Azorsa D
    Methods Mol Biol; 2011; 700():271-90. PubMed ID: 21204040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi in functional genomics.
    Scherr M; Eder M
    Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small non-coding RNAs as magic bullets.
    Eckstein F
    Trends Biochem Sci; 2005 Aug; 30(8):445-52. PubMed ID: 15996867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide identification of small RNA targets based on target enrichment and microarray hybridizations.
    Franco-Zorrilla JM; Del Toro FJ; Godoy M; Pérez-Pérez J; López-Vidriero I; Oliveros JC; García-Casado G; Llave C; Solano R
    Plant J; 2009 Sep; 59(5):840-50. PubMed ID: 19453461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.
    Rao DD; Senzer N; Cleary MA; Nemunaitis J
    Cancer Gene Ther; 2009 Nov; 16(11):807-9. PubMed ID: 19713999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide application of RNAi to the discovery of potential drug targets.
    Ito M; Kawano K; Miyagishi M; Taira K
    FEBS Lett; 2005 Oct; 579(26):5988-95. PubMed ID: 16153642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid conditional knock-down-knock-in system for mammalian cells.
    Hölzel M; Rohrmoser M; Orban M; Hömig C; Harasim T; Malamoussi A; Gruber-Eber A; Heissmeyer V; Bornkamm G; Eick D
    Nucleic Acids Res; 2007; 35(3):e17. PubMed ID: 17169998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting RNA-interference pathway with small molecules.
    Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
    Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi: running interference for the cell.
    Kent OA; MacMillan AM
    Org Biomol Chem; 2004 Jul; 2(14):1957-61. PubMed ID: 15254617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structure-activity relationship study of siRNAs with structural variations.
    Chang CI; Hong SW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi living-cell microarrays for loss-of-function screens in Drosophila melanogaster cells.
    Wheeler DB; Bailey SN; Guertin DA; Carpenter AE; Higgins CO; Sabatini DM
    Nat Methods; 2004 Nov; 1(2):127-32. PubMed ID: 15782175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noise amidst the silence: off-target effects of siRNAs?
    Jackson AL; Linsley PS
    Trends Genet; 2004 Nov; 20(11):521-4. PubMed ID: 15475108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA vs. shRNA: similarities and differences.
    Rao DD; Vorhies JS; Senzer N; Nemunaitis J
    Adv Drug Deliv Rev; 2009 Jul; 61(9):746-59. PubMed ID: 19389436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.